Appendix B: Panel Roster and Financial Disclosures
Candidiasis
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Michail Lionakis* | National Institutes of Health | None | N/A |
| Michael Mansour | Massachusetts General Hospital | GenMark Diagnostics | Scientific Advisory Board |
Genetech Thermo Fisher Scientific | Research Support (paid to institution) | ||
| Sorrento Therapeutics | Equity Interest | ||
Vericel Pulsethera NED Biosystems Day Zero Diagnostics Clear Creek Bio | Consultant | ||
| Jeniel Nett | University of Wisconsin–Madison, School of Medicine and Public Health | None | N/A |
| Jack Sobel | Wayne State University School of Medicine | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. | |||
Download Guidelines
- Section Only PDF (21.02 KB)
- Full Guideline PDF (5.96 MB)
- Tables Only PDF (928.12 KB)